Clinical Trials Directory

Trials / Conditions / Glucosylceramide Beta-Glucosidase Deficiency Disease

Glucosylceramide Beta-Glucosidase Deficiency Disease

4 registered clinical trials studyying Glucosylceramide Beta-Glucosidase Deficiency Disease — 1 currently recruiting.

StatusTrialSponsorPhase
CompletedA Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients
NCT00358150
Genzyme, a Sanofi CompanyPhase 2
CompletedSafety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
NCT00364858
Genzyme, a Sanofi CompanyPhase 4
CompletedA Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Di
NCT00365131
Genzyme, a Sanofi CompanyPhase 4
RecruitingInternational Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943
Genzyme, a Sanofi Company—